Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type

British Journal of Haematology

Volumn 110, Issue 3, 2000, Pages 525-537

  Hoffmann, T ^a,d   De Libero, G ^a   Colonna, M ^b   Wodnar Filipowicz, A ^a   Passweg, J ^c   Favre, G ^c   Gratwohl, A ^c   Tichelli, A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^c KANTONSSPITAL   (Switzerland)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Clonality; Diagnosis; HLA receptor; Lymphoproliferative disorder; Natural killer

Indexed keywords

HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIGEN RECEPTOR; LYMPHOCYTE RECEPTOR; RECEPTOR ANTIBODY;

ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0033772218     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02159.x     Document Type: Article

References (44)

1. + T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody
2. Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily
3. Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes
4. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation
5. + lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function
6. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex
7. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
8. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells
9. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes
10. Alternatively spliced forms of human killer inhibitory receptors
11. A human killer inhibitory receptor specific for HLA-A1,2
12. T-cell receptor gene rearrangements as markers of lineage and clonality in T-cell neoplasms
13. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype
14. + IL-2-activated natural killer cells
15. How to recognize a foreign submarine
16. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3 (+) large granular lymphocyte leukemia
17. NK cell receptors
18. Inhibitory MHC class I receptors on NK cells and T cells
19. The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules
20. NKB1: A natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules
21. Clonal diseases of large granular lymphocytes
22. Molecular approaches to the diagnosis and evaluation of lymphoid malignancies
23. Large granular T cell lymphocytosis (LGL) is an unresolved CD8+ immune response
24. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes
25. RAG-1-deficient mice have no mature B and T lymphocytes
26. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules: Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition
27. + natural killer cells. Role in cell activation and regulation of cytolytic function
28. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells
29. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes
30. Cytokine-induced expression of killer inhibitory receptors in human T lymphocytes
31. + large granular lymphocyte (LGL)/NK-associated (Nka) expansions: Primary malignancies or secondary reactive phenomena?
32. Determination of clonality in patients who present with diagnostic dilemmas: A laboratory experience and review of the literature
33. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways
34. Polymorphism and domain variability of human killer cell inhibitory receptors
35. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V (D) J rearrangement
36. p46, A novel natural killer cell-specific surface molecule that mediates cell activation
37. Human diversity in killer cell inhibitory receptor genes
38. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors
39. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis
40. Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual
41. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
42. NIH conference. Molecular genetic analysis of human lymphoid neoplasms. Immunoglobulin genes and the c-myc oncogene
43. Ly-49 multigene family. New members of a superfamily of type II membrane proteins with lectin-like domains
44. Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes